FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susanne Osanto

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Co-author Network

Publications

TOP 3
Susanne Osanto; Gedske Daugaard; Alan Horwich; Carla Y Vossen; Hendrik Van Poppel
Reply: Seminoma stage 1: Patterns of care in Europe.
Lisa G van den Hengel; A Q M Jeanne van Steijn-van Tol; Henri H Versteeg; Rogier M Bertina; Susanne Osanto
Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
Lisa G van den Hengel; Susanne Osanto; Pieter H Reitsma; Henri H Versteeg
Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susanne Osanto (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susanne Osanto; Gedske Daugaard; Alan Horwich; Carla Y Vossen; Hendrik Van Poppel
Reply: Seminoma stage 1: Patterns of care in Europe.
BJU international 2013;111(3):E11-2.
2013: Lisa G van den Hengel; A Q M Jeanne van Steijn-van Tol; Henri H Versteeg; Rogier M Bertina; Susanne Osanto
Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
Thrombosis research 2013;131(2):187-9.
2013: Lisa G van den Hengel; Susanne Osanto; Pieter H Reitsma; Henri H Versteeg
Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide.
Haematologica 2013;98(1):153-8.
2012: Carla Y Vossen; Hein van Poppel; Gedske Daugaard; Alan Horwich; Susanne Osanto
Patterns of care in the management of seminoma stage I: results from a European survey.
BJU international 2012;110(4):524-31.
2012: F J S H Woei-A-Jin; M D De Kruif; P Garcia Rodriguez; Susanne Osanto; Rogier M Bertina
Microparticles expressing tissue factor are concurrently released with markers of inflammation and coagulation during human endotoxemia.
Journal of thrombosis and haemostasis : JTH 2012;10(6):1185-8.
2012: Yongjun Qin; Henk P J Buermans; Susanne Osanto; Jacoba J Out-Luiting; Leslie van der Fits; Marloes S van Kester; Maarten H Vermeer; Rein Willemze; Cornelis P Tensen
Deep-sequencing analysis reveals that the miR-199a2/214 cluster within DNM3os represents the vast majority of aberrantly expressed microRNAs in Sézary syndrome.
The Journal of investigative dermatology 2012;132(5):1520-2.
2012: Yuana Yuana; Susanne Osanto; Rogier M Bertina
Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2012;23(3):244-50.
2012: Camillo Porta; Alain Ravaud; Ulka Nitin Vaishampayan; Susanne Osanto; Ashok Panneerselvam; Oezlem Anak; Sergio Bracarda; Emiliano Calvo; Miguel A Climent; Bernard Escudier; Viktor Grünwald; Thomas E Hutson; Dennis Kim; Robert J Motzer
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.
European urology 2012;61(4):826-33.
2012: Bernard Escudier; Alex Franklin; Martin Gore; Per Hartvig Honoré; Börje Ljungberg; Peter Mulders; Susanne Osanto; Camillo Porta; Alain Ravaud; Jeanne van Steijn; John Wagstaff; Zeba Aziz; Joaquim Bellmunt; Axel Bex; Sergio Bracarda; Hideyuki Akaza
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies.
Cancer treatment reviews 2012;38(2):127-32.
2012: Peter Mulders; Paul Nathan; Susanne Osanto; Laura Pike; Emilio Porfiri; Andrew Protheroe; C M L van Herpen; Igle de Jong; Robert Hawkins; Juliane M Jürgensmeier; Bijoyesh Mookerjee; Martin E Gore
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study.
European journal of cancer (Oxford, England : 1990) 2012;48(4):527-37.
2012: Susanne Osanto; Hendrik Van Poppel
Emerging novel therapies for advanced prostate cancer.
Therapeutic advances in urology 2012;4(1):3-12.
2012: Yascha W van den Berg; Susanne Osanto; Pieter H Reitsma; Henri H Versteeg
The relationship between tissue factor and cancer progression: insights from bench and bedside.
Blood 2012;119(4):924-32.
2012: Susanne Osanto; Yongjun Qin; Johannes Berkers; Henk P Buermans; Jelle J Goeman; Evelyne Lerut; Hendrik van Poppel
Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.
PloS one 2012;7(6):e38298.
2011: Hans-Joachim Schmoll; Lawrence Einhorn; Koji Kawai; Susanne Osanto; Karim Fizazi
Advanced seminoma and nonseminoma: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Urology 2011;78(4 Suppl):S456-68.
2011: Els Verdegaal; Marten Visser; John B A G Haanen; Ellen Kapiteijn; Johan W R Nortier; Tamara H Ramwadhdoebé; Sjoerd H van der burg; Caroline E van der Minne; Jeanne A Q M J van Steijn; Susanne Osanto
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.
Cancer immunology, immunotherapy : CII 2011;60(7):953-63.
2011: Camillo Porta; Susanne Osanto; Alain Ravaud; Miguel-Angel Climent; Ulka Nitin Vaishampayan; Dorothy A White; Patricia Creel; Brenda Dickow; Patricia Fischer; Suzanne Sweeney Gornell; Federica Meloni; Robert J Motzer
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2011;47(9):1287-98.
2011: Yuana Yuana; Rogier M Bertina; Susanne Osanto
Pre-analytical and analytical issues in the analysis of blood microparticles.
Thrombosis and haemostasis 2011;105(3):396-408.
2011: Johannes J A Auwerda; Yuana Yuana; Susanne Osanto; Moniek P M de Maat; Pieter Sonneveld; Rogier M Bertina; Frank W G Leebeek
Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.
Thrombosis and haemostasis 2011;105(1):14-20.
2010: P Garcia Rodriguez; H C J Eikenboom; M E T Tesselaar; Menno V Huisman; Mathilde Nijkeuter; Susanne Osanto; Rogier M Bertina
Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism.
Thrombosis research 2010;126(4):345-9.
2010: Esther M de Kruijf; Johanna G H van Nes; Anita Sajet; Quirijn R J G Tummers; Hein Putter; Susanne Osanto; Frank M Speetjens; Vincent T H B M Smit; GJ Liefers; Cornelis J H van de Velde; Peter Kuppen
The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(4):1272-80.
2010: Y Yuana; Tjerk H Oosterkamp; S Bahatyrova; B Ashcroft; P Garcia Rodriguez; Rogier M Bertina; Susanne Osanto
Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles.
Journal of thrombosis and haemostasis : JTH 2010;8(2):315-23.
2010: Susanne Osanto; Hein van Poppel
A critical need for national guidelines.
Onkologie 2010;33(7):351-2.
2009: Susanne Osanto; Hendrik van Poppel; Jacobus Burggraaf; Reginald R Hall
Hurdles in modern trial management: as overbureaucracy and commercialization of clinical trials suffocate independent academic research, it's time for a change.
European urology 2009;56(4):622-4.
2008: Bart E P B Ballieux; NI Weijl; Hans Gelderblom; Johannes van Pelt; Susanne Osanto
False-positive serum human chorionic gonadotropin (HCG) in a male patient with a malignant germ cell tumor of the testis: a case report and review of the literature.
The oncologist 2008;13(11):1149-54.
2007: M E T Tesselaar; Susanne Osanto
Risk of venous thromboembolism in lung cancer.
Current opinion in pulmonary medicine 2007;13(5):362-7.
2007: Els Verdegaal; Conny Hoogstraten; Maro H Sandel; Peter Kuppen; Antoinette A T P Brink; Frans H J Claas; Michael C B Gorsira; J Frans Graadt van Roggen; Susanne Osanto
Functional CD8+ T cells infiltrate into nonsmall cell lung carcinoma.
Cancer immunology, immunotherapy : CII 2007;56(5):587-600.
2007: M E T Tesselaar; Fred P H T M Romijn; Irma van der Linden; Frans A Prins; Rogier M Bertina; Susanne Osanto
Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
Journal of thrombosis and haemostasis : JTH 2007;5(3):520-7.
2006: Marieke Griffioen; Jan H. Kessler; Martina Borghi; Ronald A van Soest; Caroline E van der Minne; Jan Nouta; Sjoerd H van der burg; Jan Paul Medema; Peter I Schrier; J H Frederik Falkenburg; Susanne Osanto; Cornelis J M Melief
Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(10):3130-6.
2006: Jeanet W Blom; J P M Vanderschoot; MJ Oostindiër; Susanne Osanto; Felix J M van der Meer; Frits R Rosendaal
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study.
Journal of thrombosis and haemostasis : JTH 2006;4(3):529-35.
2006: Jeanet W Blom; Susanne Osanto; Frits R Rosendaal
High risk of venous thrombosis in patients with pancreatic cancer: a cohort study of 202 patients.
European journal of cancer (Oxford, England : 1990) 2006;42(3):410-4.
2005: Nicolas van Baren; Marie-Claude Bonnet; Brigitte Dréno; Amir Khammari; Thierry Dorval; Sophie Piperno-Neumann; Danielle Liénard; Daniel Speiser; Marie Marchand; Vincent G Brichard; Bernard Escudier; Sylvie Négrier; Pierre-Yves Dietrich; Dominique Maraninchi; Susanne Osanto; Ralf G Meyer; Gerd Ritter; Philippe Moingeon; Jim Tartaglia; Pierre van der Bruggen; Pierre G Coulie; Thierry Boon
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(35):9008-21.
2005: Jeanet W Blom; C J M Doggen; Susanne Osanto; Frits R Rosendaal
Old and new risk factors for upper extremity deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2471-8.
2005: C J Rooden; M E T Tesselaar; Susanne Osanto; Frits R Rosendaal; Menno V Huisman
Deep vein thrombosis associated with central venous catheters - a review.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2409-19.
2005: Jeanet W Blom; C J M Doggen; Susanne Osanto; Frits R Rosendaal
Malignancies, prothrombotic mutations, and the risk of venous thrombosis.
JAMA : the journal of the American Medical Association 2005;293(6):715-22.
2004: Jeanet W Blom; Susanne Osanto; Frits R Rosendaal
The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma.
Journal of thrombosis and haemostasis : JTH 2004;2(10):1760-5.
2004: M E T Tesselaar; Jan Ouwerkerk; MA Nooy; Frits R Rosendaal; Susanne Osanto
Risk factors for catheter-related thrombosis in cancer patients.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2253-9.
2004: Marieke Griffioen; Martina Borghi; Peter I Schrier; Susanne Osanto; Dirk Schadendorf
Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates.
Cancer immunology, immunotherapy : CII 2004;53(8):715-22.
2004: NI Weijl; TJ Elsendoorn; Eef G W M Lentjes; GD Hopman; A Wipkink-Bakker; Ailko H Zwinderman; FJ Cleton; Susanne Osanto
Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.
European journal of cancer (Oxford, England : 1990) 2004;40(11):1713-23.
2004: NI Weijl; TJ Elsendoorn; Ralf M W Moison; Eef G W M Lentjes; R Brand; Howard M Berger; Susanne Osanto
Non-protein bound iron release during chemotherapy in cancer patients.
Clinical science (London, England : 1979) 2004;106(5):475-84.
2004: Elisabeth H Slager; Caroline E van der Minne; Margreet Krüse; Dilja D Krueger; Marieke Griffioen; Susanne Osanto
Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(8):5095-102.
2004: Elisabeth H Slager; Caroline E van der Minne; Jaap Goudsmit; Johanna M M van Oers; Stefan Kostense; Menzo J E Havenga; Susanne Osanto; Marieke Griffioen
Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber.
Cancer gene therapy 2004;11(3):227-36.
2003: Renée M Y Barge; Susanne Osanto; W A Erik Marijt; C W J Ingrid Starrenburg; Willem E Fibbe; J W R Hans Nortier; J H Frederik Falkenburg; Rein Willemze
Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors.
Experimental hematology 2003;31(10):865-72.
2003: Peter Loudon; Cornelia S McLean; Gilly Martin; Jayne Curry; M Leigh Shaw; Conny Hoogstraten; Els Verdegaal; Susanne Osanto
Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma.
The journal of gene medicine 2003;5(5):407-16.
2003: Elisabeth H Slager; Martina Borghi; Caroline E van der Minne; Corlien A Aarnoudse; Menzo J E Havenga; Peter I Schrier; Susanne Osanto; Marieke Griffioen
CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1490-7.
2001: TJ Elsendoorn; NI Weijl; S Mithoe; Ailko H Zwinderman; FJ van Dam; Franz A de Zwart; Ad D Tates; Susanne Osanto
Chemotherapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo.
Mutation research 2001;498(1-2):145-58.
2001: Marieke Griffioen; Martina Borghi; Peter I Schrier; Susanne Osanto
Detection and quantification of CD8(+) T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay.
International journal of cancer. Journal international du cancer 2001;93(4):549-55.
2000: Judith Raber-Durlacher; NI Weijl; M Abu Saris; B de Koning; Ailko H Zwinderman; Susanne Osanto
Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2000;8(5):366-71.
2000: NI Weijl; M F Rutten; Ailko H Zwinderman; HJ Keizer; MA Nooy; Frits R Rosendaal; FJ Cleton; Susanne Osanto
Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(10):2169-78.
2000: Susanne Osanto; P P Schiphorst; NI Weijl; N Dijkstra; A Van Wees; N Brouwenstein; Norbert Vaessen; J H J M van Krieken; Jo Hermans; FJ Cleton; Peter I Schrier
Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line.
Human gene therapy 2000;11(5):739-50.
1999: Els Verdegaal; D B Huinink; Conny Hoogstraten; A K Marijnissen; M B Gorsira; Frans H J Claas; Susanne Osanto
Isolation of broadly reactive, tumor-specific, HLA Class-I restricted CTL from blood lymphocytes of a breast cancer patient.
Human immunology 1999;60(12):1195-206.
1999: P P Schiphorst; P C Chang; N Clar; R C Schoemaker; Susanne Osanto
Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1381-3.
1998: NI Weijl; GD Hopman; A Wipkink-Bakker; Eef G W M Lentjes; Howard M Berger; FJ Cleton; Susanne Osanto
Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(12):1331-7.
1998: Nathalie Brouwenstijn; Conny Hoogstraten; Els Verdegaal; CW van der Spek; Joan Deckers; A Mulder; Susanne Osanto; Peter I Schrier
Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(6):427-34.
1997: A van Elsas; Corlien A Aarnoudse; Caroline E van der Minne; CW van der Spek; Nathalie Brouwenstijn; Susanne Osanto; Peter I Schrier
Transfection of IL-2 augments CTL response to human melanoma cells in vitro: immunological characterization of a melanoma vaccine.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(5):343-53.
1997: NI Weijl; FJ Cleton; Susanne Osanto
Free radicals and antioxidants in chemotherapy-induced toxicity.
Cancer treatment reviews 1997;23(4):209-40.
1996: Nathalie Brouwenstijn; B Gaugler; K M Krüse; CW van der Spek; A Mulder; Susanne Osanto; Benoît J Van den Eynde; Peter I Schrier
Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
International journal of cancer. Journal international du cancer 1996;68(2):177-82.
1994: Ad D Tates; FJ van Dam; Adayapalam T Natarajan; A H Zwinderman; Susanne Osanto
Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: a prospective study.
Mutation research 1994;307(1):293-306.
1993: NI Weijl; D Van der Harst; Anneke Brand; Y Kooy; S Van Luxemburg; J Schroder; Eef G W M Lentjes; Jon van Rood; F J Cleton; Susanne Osanto
Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1376-83.
1993: Susanne Osanto; N Brouwenstÿn; N Vaessen; Carl Figdor; C J Melief; P I Schrier
Immunization with interleukin-2 transfected melanoma cells. A phase I-II study in patients with metastatic melanoma.
Human gene therapy 1993;4(3):323-30.
1992: Susanne Osanto; A Bukman; F Van Hoek; P J Sterk; J A De Laat; J Hermans
Long-term effects of chemotherapy in patients with testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):574-9.
1992: Susanne Osanto; R Jansen; M Vloemans
Downmodulation of c-myc expression by interferon gamma and tumour necrosis factor alpha precedes growth arrest in human melanoma cells.
European journal of cancer (Oxford, England : 1990) 1992;28A(10):1622-7.
1991: M R Schaafsma; J H Frederik Falkenburg; JE Landegent; N Duinkerken; Susanne Osanto; P Ralph; K Kaushansky; G Wagemaker; J Van Damme; Rein Willemze
In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients.
Blood 1991;78(8):1981-7.
1991: Susanne Osanto; MT van den Barselaar; Jaap T van Dissel
Increased intracellular killing of bacteria in vitro by monocytes of patients with metastatic melanoma before and during treatment with interferon-gamma and interferon-alpha.
European journal of cancer (Oxford, England : 1990) 1991;27(4):478-82.
1991: Susanne Osanto; J C Thijssen; V M Woldering; J L van Rijn; Adayapalam T Natarajan; Ad D Tates
Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma.
Environmental and molecular mutagenesis 1991;17(2):71-8.
1990: M R Schaafsma; Willem E Fibbe; D van der Harst; N Duinkerken; Anneke Brand; Susanne Osanto; C R Franks; Rein Willemze; J H Frederik Falkenburg
Increased numbers of circulating haematopoietic progenitor cells after treatment with high-dose interleukin-2 in cancer patients.
British journal of haematology 1990;76(2):180-5.
1989: Susanne Osanto; Anneke Brand; Jon van Rood; F J Cleton
[Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells].
Nederlands tijdschrift voor geneeskunde 1989;133(28):1392-5.
1989: L J van 't Veer; Boudewijn M T Burgering; R Versteeg; A J Boot; D J Ruiter; Susanne Osanto; Peter I Schrier; Johannes L Bos
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
Molecular and cellular biology 1989;9(7):3114-6.
1989: Susanne Osanto; R Jansen; Albert M I H Naipal; J W Gratama; A van Leeuwen; F J Cleton
In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.
International journal of cancer. Journal international du cancer 1989;43(6):1001-6.
1988: Susanne Osanto; F H Cluitmans; C R Franks; H A Bosker; F J Cleton
Myocardial injury after interleukin-2 therapy.
Lancet 1988;2(8601):48-9.
1984: E K Pauwels; F J Cleton; Susanne Osanto
[Scintigraphic studies in the detection of cancer using anti-tumor monoclonal antibodies].
Nederlands tijdschrift voor geneeskunde 1984;128(17):805-9.